8 completed, 2 terminated. 4 Phase 3, 3 Phase 2, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 3 | Completed 3 |
| Phase 4 | 3 | Completed 3 |
Follow Promius Pharma, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis DFD06 Cream, Vehicle Cream - Psoriasis | Phase 3 | Completed | Promius Pharma, LLC | 267 | 2015-12-01 | 2018-05-15 |
| A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis DFD06-Cream, Vehicle Cream - Chronic Stable Plaque Psoriasis | Phase 3 | Completed | Promius Pharma, LLC | 265 | 2015-12-01 | 2018-05-15 |
| Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp DFD-07 Cream, Placebo Cream - Actinic Keratosis | Phase 2 | Completed | Promius Pharma, LLC | 111 | 2015-11-01 | 2020-03-17 |
| DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis DFD06 Cream, Clobetasol Propionate Cream 0.05% - Psoriasis | Phase 2 | Completed | Promius Pharma, LLC | 50 | 2014-05-08 | 2018-05-18 |
| ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis ACT01, Comp01, Comp02 - Actinic Keratosis | Phase 2 | Completed | Promius Pharma, LLC | 100 | 2014-04-01 | 2016-02-22 |
| Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis Cloderm Cream - Psoriasis | Phase 4 | Completed | Promius Pharma, LLC | 60 | 2012-10-01 | 2014-07-23 |
| Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails NAB001, Vehicle alone - Onychomycosis | Phase 3 | Terminated | Promius Pharma, LLC | 468 | 2010-09-01 | 2013-07-11 |
| Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails NAB001, Placebo control - Onychomycosis | Phase 3 | Terminated | Promius Pharma, LLC | 458 | 2010-09-01 | 2013-07-11 |
| Promiseb Topical Cream for Cradle Cap Promiseb Topical Cream, Bland emollient - Cradle Cap, Infantile Seborrheic Dermatitis | Phase 4 | Completed | Promius Pharma, LLC | 42 | 2010-03-01 | 2017-03-07 |
| Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis EpiCeram Skin Barrier Emulsion, Desonide Cream 0.05% - Atopic Dermatitis | Phase 4 | Completed | Promius Pharma, LLC | 100 | 2009-03-01 | 2017-01-30 |
Psoriasis (3) · Keratosis, Actinic (2) · Onychomycosis (2) · Complement component 5 deficiency (1) · Dermatitis, Atopic (1) · Dermatitis, Seborrheic (1)
Clobetasol (1)
United States (9) · Dominican Republic (1) · Germany (1)
Joanne Fraser, PhD (3) · Srinivas Sidgiddi, MD (3) · Joanne M Fraser, PhD (2) · Kent Allenby, MD (2)